Vivo Capital

What is Vivo Capital?

Vivo Capital is a healthcare-focused investment firm with a comprehensive multi-faceted strategy encompassing venture capital, private equity, and public equity. They operate across the healthcare industry, with investments in sectors such as Biotech, HealthTech, Medical Devices, Healthcare Services, Consumer Health, Pharmaceuticals, and Life Sciences.

From early-stage startups to expansion-level firms and even mature companies facing special situations, Vivo Capital provides a range of investment types including equity and mezzanine financing.

With a presence in the U.S. and China, they leverage their global insights and expertise to invest in innovative and dynamic companies. Vivo Capital is known for a hands-on approach in guiding companies through various stages of growth, valuing strong partnerships with management teams.

Their investment prowess is reflected in their capacity to deploy substantial capital, with a minimum investment of $10 million and a maximum of $50 million, while their sweet spot lies around $25 million. With $1.4 billion in assets under management, they have the resources to make significant, transformative investments in their chosen sectors.

Vivo Capital's specialties are varied and include early-stage ventures, expansion initiatives, management buyouts/leveraged buyouts (MBO/LBO), and investing in special situations. They target companies at different funding stages, including Seed, Series A, and Series B transactions.

Their knowledge of the diverse healthcare landscape allows them to recognize and empower companies that are poised to address unmet medical needs or introduce pivotal healthcare solutions. Vivo Capital values companies that are woman-focused among their diverse investment profile, adapting to the evolving dynamics of the healthcare industry and customer needs.